tirzepatide: the version I wish someone had shown me in week 1
tirzepatide: the version I wish someone had shown me in week 1. This is a description of what happened to me and not a plan for anybody else. 20kg over 46 weeks, never went past 10mg, and constipation stayed mild the whole way. Posting because the loud threads are all 15mg. The distribution matters more than the…
week 7 is early to draw any conclusion at all
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme.
Saving this one. It is the clearest statement of the stall problem I have read here.
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
the reflux profile is genuinely gentler than people expect coming from sema
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
sulphur burps are the signature complaint and they are not dangerous
Correction to my own post above — I said 12.5mg and I have been on 10mg since the spring. Same argument, wrong number.